- Trials with a EudraCT protocol (9)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
9 result(s) found for: Thoracentesis.
Displaying page 1 of 1.
EudraCT Number: 2013-005065-38 | Sponsor Protocol Number: ECHI-TS-2 | Start Date*: 2014-02-17 |
Sponsor Name:Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin I | ||
Full Title: Concentrations of echinocandins in ascites, pleural effusion, bile, wound secretion and cerebrospinal fluid – a pilot study | ||
Medical condition: Invasive fungal infection treated with an echinocandin and indication for paracentesis, thoracentesis, bile deviation or sampling, lumbar puncture or VAC therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018275-20 | Sponsor Protocol Number: UMCNONCO201001 | Start Date*: 2010-03-24 | ||||||||||||||||
Sponsor Name:University Medical Centre Nijmegen St Radboud | ||||||||||||||||||
Full Title: A phase II study of cediranib as palliative treatment in patients with symptomatic malignant ascites or pleural effusion | ||||||||||||||||||
Medical condition: symptomatic malignant ascites or pleural effusion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002473-23 | Sponsor Protocol Number: B9E-XM-O421 | Start Date*: 2005-03-24 |
Sponsor Name:Dr. Amalia Velasco | ||
Full Title: PHASE II TRIAL OF THE SEQUENTIAL ADMINISTRATION OF COMBINATIONS OF GEMCITABINE-CISPLATIN AND CARBOPLATIN-PACLITAXEL FOR THE TREATMENT OF PATIENTS WITH ADVANCED CARCINOMA OF THE OVARY WITH SUB-OPT... | ||
Medical condition: The Phase II trial will be performed on a population of patients with a histological or cytological diagnosis of ovarian cancer (any histological type), at stages IIIB, IIIC, IV or primary peritone... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001576-12 | Sponsor Protocol Number: SGI-110-02 | Start Date*: 2013-07-22 | |||||||||||
Sponsor Name:Astex Pharmaceuticals Inc | |||||||||||||
Full Title: A Randomized, Controlled, Open-Label, Phase 2 Trial of SGI-110 and Carboplatin in Subjects with Platinum-Resistant Recurrent Ovarian Cancer | |||||||||||||
Medical condition: Platinum-Resistant Recurrent Ovarian Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002688-26 | Sponsor Protocol Number: BAY 43-9006 / 12006 | Start Date*: 2007-02-12 | |||||||||||
Sponsor Name:Bayer Healthcare AG, D-51368 Leverkusen, Germany | |||||||||||||
Full Title: A Phase III Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy of Gemcitabine, Cisplatin and Sorafenib to Gemcitabine, Cisplatin and Placebo in First-Line Treatment of Patien... | |||||||||||||
Medical condition: The patient population includes patients with Stage IIIB (with effusion) or Stage IV NSCLC of non-squamos cell carcinoma subtype, with ECOG performance status 0 or 1, for whom treatment with gemci... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) BE (Completed) FI (Completed) GR (Completed) AT (Completed) GB (Completed) IT (Completed) NL (Completed) HU (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-015082-31 | Sponsor Protocol Number: M10-757 | Start Date*: 2010-04-07 | |||||||||||
Sponsor Name:Abbott GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2 Randomized Clinical Trial of ABT-888 in Combination with Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Subjects with Recurrent High Grade Serous Ovarian Cancer | |||||||||||||
Medical condition: Recurrent high grade serous ovarian cancer. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002182-35 | Sponsor Protocol Number: P903-25 | Start Date*: 2012-10-22 | |||||||||||
Sponsor Name:Cerexa, Inc. (subsidiary of Forest Laboratories) | |||||||||||||
Full Title: A Multicenter, Multinational, Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Ceftaroline fosamil Versus Ceftriaxone Plus Vancomycin in Adult Subjects with Community-acquired ... | |||||||||||||
Medical condition: Community-acquired bacterial pneumonia (CABP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) HU (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004273-28 | Sponsor Protocol Number: EORTC 08031 | Start Date*: 2005-11-15 | |||||||||||
Sponsor Name:European Organisation for Research and Treatment of Cancer | |||||||||||||
Full Title: A phase II feasibility trial of induction chemotherapy followed by extrapleural pneumonectomy and postoperative radiotherapy in patients with malignant pleural mesothelioma. | |||||||||||||
Medical condition: malignant pleural mesothelioma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005245-19 | Sponsor Protocol Number: BAY 43-9006 / 11961 | Start Date*: 2006-05-02 | |||||||||||
Sponsor Name:Bayer Pharmaceuticals Corporation | |||||||||||||
Full Title: A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel plus or minus Sorafenib (BAY 43-9006) in chemonaive patients with Stage IIIB (with effusion) - IV Non-Small... | |||||||||||||
Medical condition: Non Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) DE (Prematurely Ended) BE (Completed) ES (Prematurely Ended) GB (Prematurely Ended) HU (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.